Menlo therapeutics inc. (MNLO)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss

-40,233

-

-

-

-15,204

-

-

-

-

-

-

-

-

Operating activities
Net loss

-

-

-

-

-

-17,593

-12,847

-8,348

-12,657

-9,276

-8,173

-6,153

-5,474

Adjustments required to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

93

-

-

-

76

-

-

-

-

-

-

-

-

Depreciation and amortization

-

-

-

-

-

12

4

1

5

-

-

-

-

Depreciation and amortization

-

-

-

-

-

12

4

1

5

3

1

2

2

Changes in marketable securities and bank deposits, net

153

-

-

-

264

-

-

-

-

-

-

-

-

Changes in accrued liability for employee severance benefits, net of retirement fund profit

-13

-

-

-

30

-

-

-

-

-

-

-

-

Amortization of premium on investment securities

-

-

-

-

-

223

231

197

123

7

14

-40

-47

Stock-based compensation

1,759

3,141

1,473

1,137

950

1,074

995

747

822

235

589

312

316

Non-cash finance expenses(income), net

347

-

-

-

-23

-

-

-

-

-

-

-

-

Changes in operating asset and liabilities, net of effects of businesses acquired:
Increase in trade receivables, prepaid and other assets

9,297

-

-

-

300

-

-

-

-

-

-

-

-

Accrued interest

-

-

-

-

-

-

-

-

-

-

-

-

125

Change in operating assets and liabilities:
Accounts receivable

-

-

-

-

-

0

-93

-141

-552

-

-

-

0

Prepaid expenses and other current assets

-

-

-

-

-

1,439

-504

-1,184

-75

-

-

-

-

Prepaid expenses and other current assets

-

-

-

-

-

1,439

-504

-1,184

-75

647

936

28

179

increase in other non-current assets

3,027

-

-

-

4

-

-

-

85

0

0

0

-66

Increase (decrease) in accounts payable and accruals

856

-

-

-

-1,949

-

-

-

-

-

-

-

-

Increase in inventory

1,849

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

-

-

-

-

-

585

-2,388

1,589

1,039

-1,381

1,524

780

-303

Accrued expenses and other current liabilities

-

-

-

-

-

900

1,812

392

-385

1,656

-4,619

5,661

278

Deferred revenue

-

-

-

-

-

0

0

-8,082

-449

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-449

-449

-449

Other non-current liabilities

-

-

-

-

-

-5

-66

52

4

4

0

-3

-13

Net cash used in operating activities

-52,211

-16,414

-16,377

-15,668

-16,642

-16,617

-12,172

-12,742

-11,202

-10,157

-12,518

37

-5,584

CASH FLOWS FROM INVESTING ACTIVITIES:
Investing activities
Purchase of fixed assets

42

0

1

-128

138

-

-

-

-

-

-

-

-

Investment in bank deposits

-

5,051

43,405

26,941

8,000

16,748

26,581

10,593

72,778

4,977

49,946

997

8,228

Cash acquired through merger

38,641

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale and maturity of marketable securities and bank deposits

27,381

-

-

-

15,877

-

-

-

-

-

-

-

-

Proceeds from sales of investments

-

-

-

-

-

-

0

1,000

4,100

-

3,299

1,501

1,200

Proceeds from maturities of investments

-

-

-

-

-

12,699

34,995

17,358

22,812

11,264

10,361

6,845

14,615

Net cash provided by investing activities

65,980

13,074

-14,606

35,167

7,739

-4,071

8,296

7,765

-45,866

6,275

-36,301

7,349

7,587

CASH FLOWS FROM FINANCING ACTIVITIES:
Financing activities
Proceeds related to issuance of stock for stock-based compensation arrangements, net

140

-118

1

137

16

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock, net of issuance costs

-

-

-

-

-

-

-6

34

125,389

-

-

-

0

Net cash provided by financing activities

140

-127

172

4,933

16

2

488

34

125,389

-

-

-

0

INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH

13,909

-

-

-

-8,887

-

-

-

-

-

-

-

-

EFFECT OF EXCHANGE RATE ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH

-37

-

-

-

13

-

-

-

-

-

-

-

-

Net increase in cash and cash equivalents

-

-

-

-

-

-

-

-4,943

68,321

-

1,542

7,386

2,003

Noncash financing activities
Conversion of preferred stock to common stock

-

-

-

-

-

0

0

0

109,327

-

-

-

0